Skip to main content
OpenTrials

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

1,012 public trials 175 recruiting studies
Refine in advanced search Browse all conditions

Melanoma trial results

Active, Not Recruiting

A Phase 1/2 Study of BA3071 in Patients With Solid Tumors

NCT05180799

Conditions
Melanoma, NSCLC, Neoplasm Metastasis, +14 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Piedmont West Atlanta, Georgia, United States
  • Northwest Cancer Centers Dyer, Indiana, United States
View Trial Details
Active, Not Recruiting

Pembrolizumab and Ipilimumab After Prior Immunotherapy for Melanoma

NCT02743819

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • University of South Alabama Mobile, Alabama, United States
  • Mount Sinai Medical Center of Florida Miami Beach, Florida, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Active, Not Recruiting

Melanoma Surveillance Photography (MSP) to Improve Early Detection of Melanoma in Ultra-high and High Risk Patients

NCT04385732

Conditions
Anxiety Disorders, Anxiety and Fear, Melanoma, +13 more
Locations
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • Newcastle Skin Check Newcastle, New South Wales, Australia
  • Dermatology Clinical Trials Unit, Westmead Hospital Sydney, New South Wales, Australia
  • Melanoma Institute Australia Wollstonecraft, New South Wales, Australia
View Trial Details
Active, Not Recruiting

A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy as First-Line Treatment in Subjects With Unresectable/Metastatic Melanoma

NCT05732805

Conditions
Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Melanoma (Skin), +16 more
Locations
  • Healthcare Institution "Bobruisk Interdistrict Oncological Dispensary" Babruysk, Belarus
  • Healthcare Institution "Brest Regional Oncological Dispensary" Brest, Belarus
  • Health care institution "Grodno University Clinic" Grodno, Belarus
  • Health Institution "Gomel Regional Clinical Oncology Center" Homyel, Belarus
View all 63 locations
View Trial Details
Active, Not Recruiting

Neoadjuvant PD-1 Blockade in Patients with Stage IIB/C Melanoma

NCT03757689

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • University of Louisville Louisville, Kentucky, United States
  • Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions